Ascend Wellness Holdings, Inc. (AAWH) Financial Statements (2026 and earlier)

Company Profile

Business Address 44 WHIPPANY ROAD, SUITE 101
MORRISTOWN, NJ 07960
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments95,270100,03488,25465,27983,71372,904
Cash and cash equivalent95,270100,03488,25465,27983,71372,904
Receivables34,73540,82040,64240,53936,52338,904
Inventory, net of allowances, customer advances and progress billings82,31785,58989,55297,387103,829106,819
Inventory82,31785,58989,55297,387103,829106,819
Other current assets13,33210,93210,92810,37312,19913,415
Total current assets:225,654237,375229,376213,578236,264232,042
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization21,3314,9003,2101,3551,4941,633
Operating lease, right-of-use asset124,251139,874139,067138,776137,324132,905
Intangible assets, net (including goodwill)260,698262,213255,101261,790266,185265,900
Goodwill53,99651,22549,59949,59950,03247,538
Intangible assets, net (excluding goodwill)206,702210,988205,502212,191216,153218,362
Other noncurrent assets15,36815,48916,42618,23819,89125,711
Other undisclosed noncurrent assets256,565256,879257,251262,136268,205263,666
Total noncurrent assets:678,213679,355671,055682,295693,099689,815
TOTAL ASSETS:903,867916,730900,431895,873929,363921,857
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:63,18354,63559,43558,89470,83870,078
Accounts payable22,56529,26626,41429,34637,56636,419
Accrued liabilities39,29722,57331,74027,32022,55822,440
Other undisclosed accounts payable and accrued liabilities1,3212,7961,2812,22810,71411,219
Deferred revenue1,3811,2581,3941,5661,5211,401
Debt26,14581,40673,88173,73919,76221,820
Other liabilities5,0305,2045,0606,6186,8787,371
Other undisclosed current liabilities5,0515,4154,7714,3124,0572,765
Total current liabilities:100,790147,918144,541145,129103,056103,435
Noncurrent Liabilities
Long-term debt and lease obligation, including:323,437251,610234,542232,162289,530288,698
Finance lease, liability25,7653,6262,0217779221,061
Other undisclosed long-term debt and lease obligation297,672247,984232,521231,385288,608287,637
Liabilities, other than long-term debt451,486464,503449,547429,673419,234393,894
Deferred income tax liabilities20,92223,52523,43925,56830,26732,477
Other liabilities184,462173,337158,887136,691122,46898,718
Operating lease, liability246,102267,641267,221267,414266,499262,699
Total noncurrent liabilities:774,923716,113684,089661,835708,764682,592
Total liabilities:875,713864,031828,630806,964811,820786,027
Equity
Equity, attributable to parent, including:27,33151,87670,97888,086116,493134,780
Additional paid in capital471,149471,285471,129471,436471,587468,093
Accumulated deficit(444,021)(419,614)(400,356)(383,565)(355,309)(333,525)
Other undisclosed equity, attributable to parent203205205215215212
Equity, attributable to noncontrolling interest8238238238231,0501,050
Total equity:28,15452,69971,80188,909117,543135,830
TOTAL LIABILITIES AND EQUITY:903,867916,730900,431895,873929,363921,857

Income Statement (P&L) ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Revenues127,304127,997136,006141,647141,536142,410
Cost of revenue(85,912)(88,436)(89,135)(97,918)(99,963)(90,373)
Gross profit:41,39239,56146,87143,72941,57352,037
Operating expenses(42,394)(37,075)(40,773)(46,146)(43,095)(49,462)
Operating income (loss):(1,002)2,4866,098(2,417)(1,522)2,575
Nonoperating expense(11,574)(10,713)(12,100)(16,072)(8,156)(8,228)
Interest and debt expense(126)(11,190) (5,475)(8,535)(8,538)
Loss from continuing operations before equity method investments, income taxes:(12,702)(19,417)(6,002)(23,964)(18,213)(14,191)
Other undisclosed income from continuing operations before income taxes12611,190 5,4758,5358,538
Loss from continuing operations before income taxes:(12,576)(8,227)(6,002)(18,489)(9,678)(5,653)
Income tax expense(11,831)(11,031)(10,789)(9,767)(12,106)(12,510)
Net loss available to common stockholders, diluted:(24,407)(19,258)(16,791)(28,256)(21,784)(18,163)

Comprehensive Income ($ in thousands)

9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
Net loss:(24,407)(19,258)(16,791)(28,256)(21,784)(18,163)
Comprehensive loss, net of tax, attributable to parent:(24,407)(19,258)(16,791)(28,256)(21,784)(18,163)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: